Long term outcomes of different revascularization strategies in left main coronary artery: a network meta-analysis

Marco Lombardi1, Juan Guido Chiabrando2, Giovanni Occhipinti3

  • 1Interventional Cardiology Unit, AOU SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; Department of Internal Medicine and Medical Specialties (DIMI), Università di Genova, Genova, Italy.

Insights

For left main coronary artery disease, imaging-guided PCI and CABG showed similar MACE outcomes. Angiography-guided PCI increased MACE risk, but all PCI strategies matched surgery for all-cause death.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Left main coronary artery (LMCA) disease requires revascularization, with choices including percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).
  • The comparative effectiveness of different PCI guidance strategies (angiography vs. imaging) against CABG for LMCA disease is not well-established.

Purpose of the Study:

  • To compare the effectiveness of angiography-guided PCI, imaging-guided PCI, and CABG for LMCA disease revascularization.
  • To evaluate risks of major adverse cardiovascular events (MACE), all-cause death, myocardial infarction, stroke, and repeat revascularization across treatment groups.

Main Methods:

  • A network meta-analysis of 17 randomized controlled trials (RCTs) involving 7700 patients undergoing LMCA revascularization.
  • Pooled incidence rate ratios (IRRs) and 95% confidence intervals (CIs) were calculated for co-primary endpoints: MACE and all-cause death.
  • Secondary endpoints included myocardial infarction (MI), stroke, target vessel revascularization (TVR), repeat revascularization, and stent thrombosis or graft occlusion.

Main Results:

  • Angiography-guided PCI showed higher MACE risk than imaging-guided PCI (IRR 1.34) and CABG (IRR 1.49).
  • No significant difference in all-cause death was found between imaging-guided PCI, CABG, and angiography-guided PCI.
  • CABG reduced MI and TVR but increased stent thrombosis/graft occlusion; angiography-guided PCI increased TVR and decreased stroke risk compared to other strategies.

Conclusions:

  • For LMCA disease, imaging-guided PCI and CABG have comparable MACE rates; angiography-guided PCI is associated with higher MACE.
  • PCI, irrespective of guidance, offers comparable all-cause death rates to CABG.
  • Imaging guidance minimizes stent thrombosis/graft occlusion, while CABG excels in reducing MI and repeat revascularization.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
495
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500